Thyrocare Technologies has appointed Nitin Chugh has been appointed as Chief Commercial Officer of the Company, being part of the Senior Management of the Company w.e.f. 22 February 2024. Powered by Capital Market - Live News

Net profit of Thyrocare Technologies rose 4.28% to Rs 15.35 crore in the quarter ended December 2023 as against Rs 14.72 crore during the previous quarter ended December 2022. Sales rose 5.24% to Rs 134.74 crore in the quarter ended December 2023 as against Rs 128.03 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales134.74128.03 5 OPM %23.4521.76 - PBDT33.3829.87 12 PBT19.9119.72 1 NP15.3514.72 4 Powered by Capital Market - Live News

Thyrocare Technologies will hold a meeting of the Board of Directors of the Company on 1 February 2024.Powered by Capital Market - Live News

Net profit of Thyrocare Technologies rose 31.82% to Rs 20.34 crore in the quarter ended September 2023 as against Rs 15.43 crore during the previous quarter ended September 2022. Sales rose 9.65% to Rs 148.00 crore in the quarter ended September 2023 as against Rs 134.97 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales148.00134.97 10 OPM %25.3523.40 - PBDT38.9232.76 19 PBT28.2723.61 20 NP20.3415.43 32 Powered by Capital Market - Live News

Thyrocare Technologies will hold a meeting of the Board of Directors of the Company on 31 October 2023.Powered by Capital Market - Live News